Skip to content
Menu
Find Partners
Ion Channel World Map
Companies
Labs
Nonprofits
Resources
Ion Channel Overview
Fundamentals
Ion Channel Drugs
Interviews
Analytics
Expert opinions
Books
Infographics
Journal Covers
Quotes
External Resources
Blog
Menu
Find Partners
Ion Channel World Map
Companies
Labs
Nonprofits
Resources
Ion Channel Overview
Fundamentals
Ion Channel Drugs
Interviews
Analytics
Expert opinions
Books
Infographics
Journal Covers
Quotes
External Resources
Blog
Industry
-
01/07/2022
Saniona reports positive results from the SAN711 Phase 1 clinical trial
Source: Saniona
Industry
-
16/12/2020
Kineta initiates Phase 1 clinical trial of its nAChR antagonist, KCP506, for the treatment of chronic pain
